Potential Treatment for ALS, Frontotemporal Dementia Targets RNA
Disney designed the ALS compound by applying nearly 15 years of research finding druggable structures on RNA.
Disney designed the ALS compound by applying nearly 15 years of research finding druggable structures on RNA.
Much of what we think of as memory loss is not a result of broken connections or age-related decline, but an important feature. A new study on transient forgetting from Davis lab at UF Florida sheds light on one element of this process.